Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (411) Arrow Down
Filter Results: (411) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (411)
    • News  (88)
    • Research  (281)
    • Events  (1)
    • Multimedia  (4)
  • Faculty Publications  (97)

Show Results For

  • All HBS Web  (411)
    • News  (88)
    • Research  (281)
    • Events  (1)
    • Multimedia  (4)
  • Faculty Publications  (97)
← Page 12 of 411 Results →

    Randall L. Tobias

    The first outsider to run the company, Tobias is credited with orchestrating a major turnaround of Eli Lilly. Under his direction, Lilly introduced two successful drugs (Zyprexa for schizophrenia and Gemzar for cancer), solidified and... View Details
    Keywords: Healthcare
    • 15 Dec 2024
    • News

    After Ozempic

    billion to expand production and improve human health across the globe. Yet, skepticism persists. In September, Vermont Senator Bernie Sanders challenged Jørgensen in a Senate committee hearing on the high cost of View Details
    Keywords: Jen McFarland Flint; Illustrations by Pete Ryan; Ambulatory Health Care Services; Health, Social Assistance
    • 01 Dec 2017
    • News

    2017 in Health Care: Telemedicine Has Arrived

    help achieve better access to care and a lower cost of care. And employers are embracing telemedicine as a way to provide employees convenient health care at a lower cost for their companies. A survey... View Details
    Keywords: Halle Tecco (MBA 2011), founder emeritus, Rock Health; angel investor; adjunct professor, Columbia Business School
    • Web

    Suppliers - Institute For Strategy And Competitiveness

    carefully examine the outcomes relative to cost for every new drug and device introduced. Key Action Steps for Suppliers Base strategies on creating unique value for patients Focus on cycles of care rather... View Details
    • 20 Aug 2014
    • News

    With No Time to Lose

    development and realized two things: First, without industry involvement there can’t be a treatment for ALS, because developing a single drug costs hundreds of millions of dollars. Second, that View Details
    Keywords: Margie Kelley
    • 01 Dec 2019
    • News

    The Race Against Resistance

    causes pneumonia in ICU patients. When the drug goes to market, the company plans to have data to back up its price. “If we say, for instance, that we can wean a patient off a ventilator three days sooner and we get a patient out of the... View Details
    Keywords: Lisa Scanlon Mogolov
    • 04 Oct 2016
    • Blog Post

    Why We Recruit: CVS Health

    of health. Through its approximately 9,600 retail pharmacies under the CVS, Navarro and Longs Drugs brand names, more than 1,135 walk-in MinuteClinc locations, a leading pharmacy benefits manager with more than 75 million plan members, a... View Details
    Keywords: Health Care
    • 12 Jul 2006
    • Research & Ideas

    Competition the Cure for Healthcare

    the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that... View Details
    Keywords: by Roger Thompson; Health
    • 01 Dec 2013
    • News

    Your Own Medicine

    drug he has ever taken that directly targets his DMD, a rare degenerative disorder in boys that weakens the body's muscles, usually putting sufferers in wheelchairs in adolescence and shutting down their heart and lungs in their 20s. For... View Details
    Keywords: Morrell, Daniel; biomedicine; biopharmaceutical company; Ambulatory Health Care Services; Health, Social Assistance
    • 16 Sep 2016
    • News

    Gaining Ground on ALS

    Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical trials cost tens to... View Details
    • 23 Mar 2003
    • Research & Ideas

    AIDS in Africa—What’s the Solution?

    5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that... View Details
    Keywords: by Julie Jette
    • Web

    Propose an Independent Project | MBA

    Bank/Broker-dealer back-office segment Helping the CEO determine how to manage the business and political issues around the pricing and marketing of prescription drugs Analyzing the appropriateness of an... View Details
    • 01 Sep 2008
    • News

    In Africa, Porter Sees Lessons for Health Care

    delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care. Porter and his colleagues aim to... View Details
    Keywords: HIV/AIDS; Ambulatory Health Care Services; Health, Social Assistance
    • Web

    Consumer Information | MBA

    universities to publicly disclose various aspects of their policies and procedures. General HBS Policies Financial Assistance Information MBA Key Dates & Calendar Annual Cost of Attendance Leaves of Absence & Withdrawals Satisfactory... View Details
    • 01 Jun 2000
    • News

    The Business of Biotech

    $1 and $2 billion drugs will give way to $200 to $300 million drugs. That will be a very different world for big drug companies, with different cost structures and... View Details
    Keywords: Julia Hanna
    • 01 Aug 2017
    • First Look

    First Look at New Research and Ideas, August 1

    Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or “large-molecule drugs”) represent a substantial and growing share of the U.S. drug market, accounting... View Details
    Keywords: Sean Silverthorne
    • 17 Sep 2001
    • Research & Ideas

    Is There Help for the Big Ticket Buyer?

    helping individuals make wise consumption decisions. Behavioral decision researchers in consumer research have used the rationality criterion to demonstrate consumer bias, but this descriptive research typically has not been applied View Details
    Keywords: by Max H. Bazerman
    • 07 Aug 2000
    • Research & Ideas

    The Business of Biotech

    will give way to $200 to $300 million drugs. That will be a very different world for big drug companies, with different cost structures and resource-allocation processes." And the View Details
    Keywords: by Julia Hanna; Biotechnology; Health; Technology
    • 11 Aug 2003
    • Research & Ideas

    Cheap, Fast, and In Control: How Tech Aids Innovation

    Harvard Business School, discusses how businesses can sidestep the often prohibitive costs and time-consuming trials of experimentation by implementing new technologies. Wendy Guild: We've all heard the old saw, "If it ain't broke,... View Details
    Keywords: by Wendy Guild
    • 29 Jun 2022
    • Blog Post

    Harvard Business School Announces the 2022-2023 Blavatnik Fellows

    medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin... View Details
    • ←
    • 12
    • 13
    • …
    • 20
    • 21
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.